LISA STANFORD, FNP-BC
Family Nurse Practitioner · BOYNTON BEACH, FL
Individual Active NPI 1194244228
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 348 | 257,484 | $10,551,839 | $4,780,045 | $3,805,054 |
| 2023 | 235 | 118,998 | $12,237,493 | $4,627,110 | $3,683,265 |
| 2022 | 157 | 65,717 | $10,231,669 | $3,618,298 | $2,884,383 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0174 | Injection, lecanemab-irmb, 1 mg | 84,600 | $1 | $1 |
| J1306 | Injection, inclisiran, 1 mg | 31,808 | $12 | $9 |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 28,980 | $11 | $8 |
| J0175 | Injection, donanemab-azbt, 2 mg | 11,550 | $4 | $3 |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 7,800 | $18 | $14 |
| J0897 | Injection, denosumab, 1 mg | 2,040 | $25 | $20 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 857 | $0 | $0 |
| 96372 | Injection of drug or substance under skin or into muscle | 486 | $12 | $10 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 367 | $52 | $41 |
| J3489 | Injection, zoledronic acid, 1 mg | 195 | $6 | $5 |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 137 | $17 | $14 |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 113 | $59 | $47 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | 9179520 | FL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in Florida
- NPI 1043694656
- NPI 1588291637
- NPI 1447969316
- NPI 1619528221
- NPI 1659025153
- NPI 1235721416
- NPI 1518367374
- NPI 1548909963
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.